Adma Biologics (ADMA) EBIT Margin (2011 - 2026)
Adma Biologics (ADMA) posted EBIT Margin of 42.16% for Q2 2026, up 7.08 percentage points from 35.08% a year earlier but down 8.74 percentage points from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) EBIT Margin (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Adma Biologics was 43.82%, up 11.00 percentage points year-over-year; for FY2025, it was 37.53%, up 4.93 percentage points from FY2024.
- Annual EBIT Margin has increased for five consecutive years, with a five-year change of +191.28 percentage points (FY2020 to FY2025).
- In prior years, Adma Biologics' EBIT Margin was 32.59% in FY2024 (+24.21 pp), 8.38% in FY2023 (+33.93 pp), -25.55% in FY2022 (+46.57 pp) and -72.12% in FY2021 (+81.64 pp).
- Quarterly EBIT Margin has run from a low of -69.81% in Q3 2021 to a high of 50.90% in Q1 2026 over five years.
- On a year-over-year basis, EBIT Margin has increased in each of the last four quarters, with an average year-over-year change of +10.10 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2021, with a gain of 73.39 percentage points; the weakest was Q2 2025, with a drop of 1.49 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was 50.90% (Q1 2026), 45.09% (Q4 2025) and 38.01% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Adma Biologics | 2.28 Bn | 1.86 Bn | 86.28 Mn | 42.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.16% |
| Mar 31, 2026 | 50.90% |
| Dec 31, 2025 | 45.09% |
| Sep 30, 2025 | 38.01% |
| Jun 30, 2025 | 35.08% |
| Mar 31, 2025 | 30.38% |
| Dec 31, 2024 | 32.60% |
| Sep 30, 2024 | 33.08% |
| Jun 30, 2024 | 36.57% |
| Mar 31, 2024 | 26.65% |
| Dec 31, 2023 | 19.26% |
| Sep 30, 2023 | 12.91% |
| Jun 30, 2023 | -0.79% |
| Mar 31, 2023 | -1.43% |
| Dec 31, 2022 | -12.12% |
| Sep 30, 2022 | -22.67% |
| Jun 30, 2022 | -27.06% |
| Mar 31, 2022 | -50.91% |
| Dec 31, 2021 | -50.00% |
| Sep 30, 2021 | -69.81% |
API Access
Adma Biologics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();